In order to correlate our assessment of risk score with other established prognostic markers, several well established prognostic markers such as transcriptomic classification, mutation subtype and BRAF mutant for cutaneous melanoma were obtained from the previous TCGA study [25]. This evidence concerns the gene BRAF and cutaneous melanoma.